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Lyon-Sud, Oullins, FranceIntroduction: Reducing protein intake is recommended for slowing chronic kidney disease (CKD) pro-
gression, but assessment of its true effectiveness is sparse.
Methods: Using the Maroni formula, we assessed dietary protein intake (DPI) from 24-hour urinary urea
excretion in 1594 patients (67% men and 33% women) with CKD, 784 of whom also had 7-day food re-
cords. Cause-speciﬁc hazard ratios (HRs) and 95% conﬁdence intervals for the competing risks of DPI-
associated end-stage renal disease (ESRD) or death were estimated in 1412 patients with baseline
glomerular ﬁltration rate $15 ml/min per 1.73 m2, measured by 51Cr-EDTA renal clearance (mGFR).
Results: Overall, mean DPI estimated from urea excretion was 1.09  0.30 g/kg of body weight per day
(range ¼ 0.342.76); 20% of patients had values > 1.3 g/kg per day, and 1.9% had values < 0.6 g/kg per
day. Urea excretion and food records produced similar estimates of mean DPI. The lower the mGFR, the
lower the mean DPI. Over a median follow-up of 5.6 years, there were 319 ESRD events and 189 pre-ESRD
deaths. After adjusting for relevant covariates, each 0.1 g/kg daily higher baseline urea excretionbased
DPI or food recordbased DPI was associated with an HR for ESRD of 1.05 (95% conﬁdence interval
1.011.10) or 1.09 (95% conﬁdence interval 1.041.14), respectively. HRs were stronger in patients with
baseline mGFR < 30 ml/min per 1.73 m2. There was no association with mortality. The mean age of the
patients was 59  15 years, and mean body mass index was 26.6  5.2 kg/m2.
Conclusion: In this prospective observational study, the lower the baseline DPI, the slower the progression
toward ESRD. Most importantly, the absence of threshold for the relation between DPI and ESRD risk
indicates that there is no optimal DPI in the range observed in this cohort.
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International Reports (2018) 3, 105–114D espite numerous clinical trials and observationalstudies, the effectiveness of lowering dietary
protein intake (DPI) to slow the progression of chronic
kidney disease (CKD) remains controversial,1 although
it is well established that protein restriction is beneﬁ-
cial for reducing uremic symptoms and proteinuria in
patients with CKD.2 However, insufﬁcient protein
intake, particularly in older patients, can result in105
CLINICAL RESEARCH M Metzger et al.: Low-Protein Diet and ESRD Riskmalnutrition.3 Considering both the potential beneﬁts
and harms, current guidelines suggest “lowering pro-
tein intake to 0.8 g/kg per day in adults with glomer-
ular ﬁltration rate (GFR) <30 ml/min per 1.73 m2 [.]
[and] avoiding high protein intake > 1.3 g/kg per day
in adults with CKD at risk of progression.”4
Several randomized controlled trials (RCTs) have
investigated the effects of reducing DPI on CKD pro-
gression; the largest of these was the Modiﬁcation of
Diet in Renal Disease (MDRD) Study. Although its
primary results were inconclusive,5 several secondary
analyses tend to support the conclusion that successful
DPI restriction has a beneﬁcial effect on the rate of
GFR decline, proteinuria, and end-stage renal disease
(ESRD) onset.5–9 The long-term follow-up of this
study, however, also revealed a higher risk of death
associated with very low DPI.9 The last updated
Cochrane meta-analysis, based on 10 RCTs and 2000
patients with nondiabetic CKD randomized to either
low (0.6 g/kg per day) or very low (0.30.6 g/kg per
day) DPI versus standard DPI (> 0.8 g/kg per day),
showed a 32% reduction of the combined outcome of
ESRD or mortality associated with reduced DPI.10
Adherence to low DPI was poor in all these RCTs,
however, as it is in individuals with CKD not partici-
pating in RCTs.11 Further nutritional studies are still
needed to characterize the optimal level of protein
restriction in CKD patients, in terms of compliance,
efﬁcacy, and safety.
We therefore investigated the relation of baseline DPI
with subsequent GFR decline and the risks for ESRD and
death over a 6-year period in the NephroTest cohort of
patients with CKD (all stages). Our goal was to document
whether or not there were thresholds above or below
which DPI was beneﬁcial or deleterious for ESRD risk
and below which it may be deleterious for survival. DPI
was assessed by 2 independent methods: measurement
of 24-hour urinary urea excretion (DPI-UE) in all pa-
tients, and a 7-day food record (DPI-FR) in nearly half of
them.MeasuredGFR (mGFR)was determined by urinary
clearance of 51Cr-EDTA.METHODS
Patients
NephroTest is a prospective cohort including 1835
adult patients ($ 18 years of age) with all stages of CKD
and any type of kidney disorder who were referred by
nephrologists to 3 French physiology departments for
extensive annual workups between 2000 and 2010, as
previously described.12 Patients on dialysis or living
with a kidney transplant and pregnant women were
excluded. All patients signed written informed consent
before inclusion. The ethics committee of the French106Research Ministry approved the study design (CCTIRS
MG/CP09.503).
Measurements
At baseline, all patients underwent clinical examination
and provided data about their medical history and
treatment. They also provided samples for various
laboratory measurements, including 24-hour urine to
measure daily urine volume, creatinine clearance
(24-hour Ccreat), urinary urea concentration (by spec-
trophotometer at 340 nm; AU680 Beckman Coulter
France, Villepinte, France), protein, and albumin. Daily
excretion rates of urea and creatinine, and albumin-to-
creatinine ratio (UACR) were calculated. Diabetes was
deﬁned as either fasting glycemia $ 7 mmol/l or anti-
diabetic treatment, or reported diabetes, and hyper-
tension by either a blood pressure > 140/90 mm Hg or
antihypertensive treatment.
At baseline and each follow-up visit, urinary clear-
ance of 51Cr-EDTA (mGFR) and plasma creatinine con-
centration were determined as the average of 5 to 7
consecutive 30-min clearance periods (30-min Ccreat), as
previously described.13 We compared 24-hour Ccreat to
30-minute Ccreat taken as the gold standard to estimate
the percentage of under and over 24-hour urine collec-
tion using the following equation: (1 – Ccreat ratio) 
100, where Ccreat ratio ¼ 24-hour CcreatO 30-minute
Ccreat (both expressed in ml/min). Nine patients with
percentage in absolute values exceeding 100%, that is,
Ccreat ratio > 2, were excluded. Distribution of the
Ccreat ratio is shown in Supplementary Figure S1.
Dietary Protein Intake Assessment
Protein intake at baseline was estimated from 24-hour
urinary urea excretion (UE) according to the Maroni
formula,14 as follows:
DPI-UE ðg per dÞ ¼ 6:25 ½UUNðg per dÞ
þ 0:031 body weightðkgÞ
where UUN (urinary urea nitrogen)¼ 0.028 UE (mmol/
24 h).
Before calculating UUN, all UE valuesweremultiplied
by the reverse of the Ccreat ratio in order to reduce
measurement errors resulting from either under or over
24-hour urine collection. Finally, DPI was normalized to
body weight and expressed in grams per kilogram per
day. After excluding 221 patients with missing data for
UE or Ccreat measures as well as 20 outliers for either
urea excretion (> 800 mmol/24 h or < 30 mmol/24 h),
Ccreat ratio (> 2), or DPI (> 3 g/kg per day), we analyzed
baseline data for 1594 patients with DPI-UE (Figure 1). In
a subgroup of 784 patients from 1 center, DPI was also
estimated by dieticians, based on 7-day food recordsKidney International Reports (2018) 3, 105–114
NephroTest cohort
N = 1835
n = 920            
at least 2 mGFR measurements
Missing or abnormal data 
regarding 24-hour urinary collection 
or food record: n =   241
Only 1 mGFR 
measurement: n = 492
Baseline mGFR
<15 ml/min per 1.73 m²: n = 99
n = 1594
baseline data Food record 
n = 787
Lost to follow-up: n = 83
Description of protein 
intake at baseline
using DPI-UE or DPI-FR
Survival analysis of
ESRD and death before ESRD
according to DPI-UE or DPI-FR
n = 1412
with follow-up Food recordn = 685
mGFR slope analysis
according to DPI-UE
Figure 1. Study ﬂow chart. DPI-FR, dietary protein intake estimated from 7-day food record; DPI-UE, dietary protein intake estimated from 24-
hour urinary urea excretion; ESRD, end-stage renal disease; mGFR, measured glomerular ﬁltration rate.
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before the 24-hour urine collection.Outcomes
The primary endpoints of this studywere ESRD, deﬁned
as initiation of dialysis or preemptive transplantation,
and pre-ESRD mortality. Events were identiﬁed either
from medical records or through linkage with the na-
tional Renal Epidemiology and Information Network
(REIN) and death registries.15 After excluding 99 pa-
tients with CKD stage 5 at baseline, and 83 lost to follow-
up, 1412 patients were followed up through 31
December 2013. We also studied mGFR decline as a
secondary endpoint in 920 patients with at least 2 mGFR
measurements over the study period (Figure 1).Statistical Analyses
We ﬁrst described baseline characteristics in the
overall sample of 1594 patients and compared these
characteristics between patients with and without
7-day food records. We then studied mean DPI-UE and
DPI-FR according to mGFR level, stratiﬁed into 5
classes (< 15, 1529, 3044, 4559, and $ 60 ml/min
per 1.73 m2). We also calculated the percentages of
DPI-UE (in 3 classes: < 0.8, 0.81.3, and > 1.3 g/kg
per day) by mGFR class and mean DPI-UE according to
patient characteristics. Agreement between DPI-UE
and DPI-FR was analyzed with Bland–Altman plots.16Kidney International Reports (2018) 3, 105–114Second, in the 1412 patients with CKD stages 1 to 4
at baseline, we used cause-speciﬁc Cox models to esti-
mate crude hazard ratios (HR) and 95% conﬁdence
intervals of ESRD and death before ESRD according to
DPI-UE treated continuously in decigrams per kilogram
per day, and in categories (< 0.8, 0.81.3, > 1.3 g/kg
per day). We used an intent-to-treat approach and
analyzed hazard ratios (HRs) associated with baseline
DPI-UE. In these models, the competing events of ESRD
and death before ESRD were treated as censored
observations. The cause-speciﬁc approach has been
shown to be most appropriate for accounting for
competing risks of concurrent events in etiological
studies.17 HRs were then adjusted for age, gender,
origin (sub-Saharan Africa, other), smoking, body mass
index, diabetes, elevated blood pressure (> 140/90),
renin-angiotensin system inhibitor (RASi) use, history
of cardiovascular disease, UACR (<3, 3–29, $30 mg/
mmol), serum albumin, and center. We assessed the
Cox model assumption of proportional hazards, which
was met for all covariates except GFR; this result led us
to stratify, rather than adjust for, mGFR in 6 classes in
the multivariate model for ERSD. We tested in-
teractions between diabetes, RASi use, UACR and DPI-
UE in the relation with ESRD risk, and estimated HR of
ESRD by subgroups stratiﬁed by baseline mGFR.
Penalized splines were used in fully adjusted Cox
models to represent the functional relationship be-
tween DPI-UE and ESRD risk. We also conducted 2107
Table 1. Patient characteristics, overall and by subgroup
All patients
(N [ 1594)
Without FR
(n [ 810)
With FR
(n [ 784)
Demographic
characteristics
Men (%) 66.6 66.2 67.1
Age (yr) 59.0  15.2 58.5  15.4 59.6  14.9
African origin (%) 13.5 14.7 12.3
Current smoking (%) 14.0 13.0 15.1
Clinical characteristics
Body mass index (kg/
m2)
26.6  5.2 26.5  5.2 26.6  5.1
Diabetesa (%) 26.5 21.0 32.3
History of CVDb (%) 18.4 16.7 20.2
Systolic BP (mm Hg) 136  20 137  21 136  20
Diastolic BP (mm Hg) 75  12 76  12 74  12
Hypertensionc (%) 91.7 90.0 93.5
Elevated BPd (%) 37.5 37.6 37.5
RASi use (%) 77.4 76.9 77.9
Laboratory
measurements
mGFR (ml/min per
1.73 m2)
38.2 [26.653.4] 40.2 [27.354.0] 36.5 [25.652.2]
UACR (mg/mmol) 8.9 [1.745.3] 7.3 [1.341.9] 10.8 [2.348.9]
UACR $ 30 mg/mmol
(%)
31.8 29.8 34.0
Serum albumin
(g/l)
39.3  4.5 39.9  4.1 38.7  4.7
Nutritional characteristics
Protein intake
(g/kg per d)
Estimated from
24-h UE
1.09  0.3 1.06  0.24 1.13  0.34
Estimated from
7-day FR
1.12  0.34
Energy intakee (kcal/
kg per d)
26  8
Data are mean  SD, median [interquartile range], or percentage.
BP, blood pressure; CVD, cardiovascular disease; FR, food record; mGFR, measured
glomerular ﬁltration rate; RASi, renin-angiotensin system inhibitor; UACR, urinary
albumin-to-creatinine ratio; UE, urea excretion.
aDiabetes defined as fasting glycemia > 7 mmol/l or antidiabetic treatment or reported
diabetes.
bHistory of CVD includes myocardial infarction, angioplasty/coronary artery bypass
graft, stroke, heart failure.
cHypertension defined as BP > 140/90 mm Hg or antihypertensive treatment.
dElevated BP defined as systolic BP > 140 mm Hg or diastolic BP > 90 mm Hg.
eEnergy intake estimated from food record.
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ciated with DPI-UE based on uncorrected UE values in
a subgroup of 726 patients with reliable 24-hour urine
collection, deﬁned by a urine collection bias < j15%j,
that is, a Ccreat ratio between 0.85 and 1.15, a
restrictive deﬁnition that minimized measurement er-
rors. The other estimated HRs associated with both DPI
estimates in the 784 patients with both measurements.
In the latter subgroup, we adjusted for total energy
intake, by applying the residual method to protein
intake estimated from the food records.18
Third, in the 920 patients with at least 2 mGFR
measurements, we used a linear mixed model with
random intercepts and slopes to study the association
between baseline DPI-UE and mGFR slope in milliliters
per minute per year. We estimated b and SDs adjusted
for baseline mGFR (< 30, 3044, $45 ml/min per 1.73
m2), as well as for the above covariates and the number
of mGFR measurements. The covariance matrix for the
random effects was estimated for each group of baseline
mGFR separately, and robust sandwich variance esti-
mators were used to estimate variances of regression
coefﬁcients. Interactions with time were tested for all
covariates. Only those that were statistically signiﬁcant
according to the Wald test and improved the model
according to the Akaike Information Criterion (AIC)
were included in the ﬁnal model. All analyses were
performed with SAS version 9.3 software (SAS Insti-
tute, Cary, NC).
RESULTS
Baseline Patient Characteristics
Among the 1594 patients, 59% were men and 14%
were from sub-Saharan Africa or the French West In-
dies (Table 1). About 20% were obese (body mass
index $ 30 kg/m2), 25% had diabetes, and more than a
third had high blood pressure. Half of them had CKD
stage 3, and 33% CKD stage 4 or 5. All patients had
DPI-UE estimated at baseline; in 1 of the 3 study cen-
ters, which included 784 patients, they also had DPI-
FR. Patients with and without DPI-FR did not differ
signiﬁcantly in regard to demographic characteristics
or most clinical data, except diabetes, which was more
common in patients with DPI-FR. However, mGFR
tended to be lower and UACR tended to be higher in
patients with than without DPI-FR.
Agreement Between the 2 Dietary Protein
Intake Estimates
In the subgroup of patients whose DPI was estimated by
both methods, mean DPI-UE and DPI-FR were very
similar (1.13  034 vs. 1.12  0.34), respectively
(Table 1). Therewas no bias between the 2methods (mean
difference¼0.02 0.40 g/kg per day; 95%CI¼0.05
108to 0.01), with no variation in difference according to DPI
level, but the BlandAltman plot showed relatively poor
agreement (Supplementary Figure S2).
Dietary Protein Intake According to Patient
Characteristics and mGFR at Baseline
Mean DPI-UE was 1.09  0.30 g/kg per day (5th95th
percentiles: 0.681.62). It was lower with older age,
higher body mass index, serum albumin, and total
energy intake, but was not associated with gender,
origin, smoking, diabetes status, or UACR (Table 2).
In the overall cohort, the lower the mGFR, the lower
the mean DPI-UE (P for trend < 0.01); a similar trend
was observed for DPI-FR (P for trend < 0.01) (Figure 2).
Overall, 20% of the patients had DPI-UE > 1.3 g/kgKidney International Reports (2018) 3, 105–114
Table 2. Dietary protein intake estimated from 24-hour urinary urea
excretion (in g/kg per day) according to patient characteristics
n
DPI-UE
Mean ± SD P value
Gender
Men 1062 1.10  0.28 0.1
Women 532 1.08  0.31
Age (yr)
<50 428 1.13  0.29 0.006
5059 347 1.09  0.30
6069 359 1.08  0.29
$70 460 1.07  0.31
African origin
No 1327 1.10  0.30 0.07
Yes 207 1.06  0.27
Current smoking
No 1371 1.09  0.30 0.3
Yes 223 1.11  0.29
Body mass index (kg/m2)
<19 56 1.30  0.37 <.0001
1924 611 1.16  0.30
2529 585 1.07  0.26
$30 342 0.97 0.26
Diabetesa
No 1166 1.10  0.29 0.6
Yes 423 1.09  0.31
History of CVDb
No 1301 1.09  0.29 0.6
Yes 293 1.08  0.31
Elevated BPc
No 962 1.11  0.29 0.002
Yes 578 1.06  0.30
RASi use
No 343 1.11  0.31 0.3
Yes 1174 1.09  0.29
UACR (mg/mmol)
<3 517 1.10  0.28 0.2
329 542 1.11  0.31
$30 494 1.07  0.30
Serum albumin (g/l)
<35 223 1.04  0.30 <.0001
3539 637 1.06  0.30
$40 691 1.14  0.29
Energy intake (kcal/kg per d)d
<21.6 260 1.04  0.31 <.0001
21.627.8 261 1.12  0.32
$27.9 262 1.23  0.35
BP, blood pressure; CVD, cardiovascular disease; DPI-UE, dietary protein intake esti-
mated from 24-hour urinary urea excretion; RASi, renin-angiotensin system inhibitor;
UACR, urinary albumin-to-creatinine ratio.
aDiabetes defined as fasting glycemia >7 mmol/l, antidiabetic treatment, or reported
diabetes.
bHistory of CVD includes myocardial infarction, angioplasty/coronary artery bypass
graft, stroke, heart failure.
cElevated BP defined as systolic BP > 140 mm Hg or diastolic BP > 90 mm Hg.
dEnergy intake estimated from 7-day food records in the subgroup with food records
and urea excretion measurements.
Figure 2. Distribution of dietary protein intake (DPI) in grams per
kilogram per day according to measured glomerular ﬁltration rate
(mGFR). (a) DPI estimated from 24-hour urinary urea excretion (UE) in
the overall sample (N ¼ 1594). (b) DPI estimated from 7-day food
record (FR) in the subsample (n ¼ 784). Diamonds represent mean
values; boxes show the median values and the interquartile range.
Whiskers extend to 1.5 times the interquartile range.
M Metzger et al.: Low-Protein Diet and ESRD Risk CLINICAL RESEARCHper day and 14% had DPI-UE < 0.8 g/kg per day. Only
31 patients (1.9%) had DPI-UE < 0.6 g/kg per day. The
prevalence of high DPI-UE (> 1.3 g/kg per day) was
higher and that of low DPI-UE (<0.8 g/kg per day)
lower at high than at low mGFR (Figure 3).Kidney International Reports (2018) 3, 105–114Hazard Ratios for ESRD and Pre-ESRD Death,
According to Baseline Dietary Protein Intake
Over a median follow-up of 5.6 years (interquartile
range [IQR] ¼ 3.67.8), there were 319 ESRD events
and 189 deaths before ESRD. The crude hazard ratio109
Figure 3. Percentage of patients with low, normal, or excess dietary
protein intake (in grams per kilogram per day), according to
measured glomerular ﬁltration rate (mGFR).
Table 3. Hazard ratios (95% conﬁdence intervals) for ESRD in 1412
patients with CKD stages 1 to 4 at baseline
n Crude ESRD HR Adjusted ESRD HRa
All patients 1412
DPI-UE (per 0.1 g/
kg per d)
0.98 (0.941.02) 1.05 (1.011.10)
DPI-UE in classes
<0.8 versus 0.8
1.3 g/kg per d
1.08 (0.771.51) 0.89 (0.621.27)
>1.3 versus 0.8
1.3 g/kg per d
0.86 (0.651.13) 1.20 (0.891.62)
In patients with
reliable 24-h urine
collectionb
DPI-UE (per 0.1 g/
kg per d)
726 0.95 (0.881.01) 1.08 (1.011.16)
Uncorrected DPI-UE
(per 0.1 g/kg
per d)
726 0.92 (0.860.99) 1.06 (0.991.14)
In the subsample with
food records
DPI-UE (per 0.1 g/
kg per d)
685 0.97 (0.931.01) 1.04 (0.991.09)
DPI-FR (per 0.1 g/
kg per d)
685 1.04 (0.981.09) 1.09 (1.041.14)
Ccreat, creatinine clearance; CKD, chronic kidney disease; DPI-FR, dietary protein
intake estimated from 7-day food records; DPI-UE, dietary protein intake estimated from
24-hour urinary urea excretion; ESRD, end-stage renal disease; HR, hazard ratio.
aAdjusted for age, gender, body mass index (< 19, 2024, 2529, $30), origin (sub-
Saharan Africa, other), urinary albumin-to-creatinine ratio (<3, 3–29, and $30 mg/
mmol), elevated blood pressure (>140/90), history of cardiovascular disease (including
myocardial infarction, angioplasty/coronary artery bypass graft, stroke, heart failure),
current smoking, angiotensin-converting enzyme inhibitor or angiotensin receptor
blocker treatment, serum albumin, and center. Cox models were stratified for baseline
mGFR levels into 6 classes (15–19, 20–29, 30–39, 40–49, 50–59, $60 ml/min per 1.73 m2).
bReliablity of 24-h urine collection was defined as an absolute value of urine collection
bias [1 – (24-h CcreatO 30-min Ccreat)] < 15%, that is, a Ccreat ratio between 0.85 and
1.15. In this analysis, DPI-UE was estimated using uncorrected 24-h urinary urea
excretion (uncorrected DPI-UE), otherwise it was based on 24-h urinary urea excretion
multiplied by the reverse of the Ccreat ratio as in all other analyses.
CLINICAL RESEARCH M Metzger et al.: Low-Protein Diet and ESRD Risk(HR) for ESRD was signiﬁcantly higher in patients with
diabetes, high blood pressure, cardiovascular disease,
elevated albuminuria, and in smokers than in those
without these conditions, but not with higher DPI-UE,
whether analyzed continuously or in classes (Table 3
and Supplementary Table S1). After accounting for
baseline mGFR, however, the HR for ESRD associated
with 0.1 g/kg per day higher DPI-UE was statistically
signiﬁcant and did not change after further adjustment
for the above covariates. Penalized spline regression
showed that both DPI-UE and DPI-FR had a linear no-
threshold relation with ESRD risk (Figure 4). Further
adjustment for sodium intake estimated from 24-hour
urine slightly attenuated the HR for ESRD associated
with DPI-UE (1.04, 95% conﬁdence interval
[CI] ¼ 0.91.09), but not that with DPI-FR (HR ¼ 1.09,
95% CI ¼ 1.041.14). There was no signiﬁcant inter-
action with diabetes, RASi use, or UACR in the relation
between DPI-UE and ESRD risk (all interaction P values
> 0.35). The HR for ESRD associated with 0.1 g/kg per
day higher DPI-UE nevertheless tended to be slightly
higher in patients with than without diabetes
(HR ¼ 1.08, 95% CI ¼ 1.011.17, vs. HR ¼ 1.04, 95%
CI ¼ 0.991.09, respectively). Analyses by baseline
mGFR showed increasing HR for ESRD with higher
DPI-UE or DPI-FR in both subgroups (Supplementary
Figure S3), but adjusted HR associated with 0.1 g/kg
per day higher DPI-UE was stronger in patients with
mGFR < 30 than $ 30 ml/min per 1.73 m2 (HR ¼ 1.09,
95% CI ¼ 1.031.15, n ¼ 409, P ¼ 0.002, vs.
HR ¼ 1.03, 95% CI 0.961.10, n ¼ 1003, P ¼ 0.41).
Sensitivity analyses conducted in the patient sub-
group with reliable urine collection (see Materials and
Methods) as well as in that with both DPI estimates
yielded similar ﬁndings (Table 3). In the latter subgroup,110further adjustment for total calorie intake slightly
reduced its HR to 1.06 (95% CI ¼ 1.001.13; P ¼ 0.04).
In this model, the HR for ESRD associated with total
calorie intake also rose signiﬁcantly (HR ¼ 1.06, 95%
CI ¼ 1.021.10) per 100 kcal higher per day.
In contrast, the HR for pre-ESRDdeath associatedwith
low DPI-UE (<0.8 g/kg per day) was not statistically
signiﬁcant either before or after adjusting for con-
founders (Supplementary Table S2). Of note, older pa-
tients, men, those with diabetes, low bodymass index, or
a history of cardiovascular disease, and smokers were at
higher risk for death, whereas African patients and those
with higher mGFR and serum albumin had lower risk.
Baseline Dietary Protein Intake and Subsequent
mGFR Decline
In 920 patients with at least 2 visits (median number
[IQR], 3 [25] per patient) over a mean follow-up of 4.0
 2.6 years, the mean mGFR decline was 1.46 0.09
ml/min per year; it was steeper in patients with a
higher mGFR at baseline (Table 4). In the mixed model
adjusted for baseline mGFR and patient characteristics,
each 0.1 g/kg per day higher DPI-UE at baseline wasKidney International Reports (2018) 3, 105–114
Figure 4. Hazard ratio for end-stage renal disease (ESRD) according to dietary protein intake estimated from 24-hour urinary urea excretion (UE)
or 7-day food records (FR). Continuous lines represent predictions with penalized splines in Cox models (95% conﬁdence intervals in color).
Ticks on the x-axis represent the distribution of dietary protein intake (DPI). Hazard ratios are adjusted for age, gender, body mass index (< 19,
2024, 2529, $ 30), origin (sub-Saharan Africa, other), urinary albumin-to-creatinine ratio (<3, 3–29, and $30 mg/mmol), elevated blood
pressure (> 140/90), history of cardiovascular disease (including myocardial infarction, angioplasty/coronary artery bypass graft, stroke, heart
failure), current smoking, angiotensin-converting enzyme inhibitor or angiotensin receptor blocker treatment, serum albumin, and center. Cox
models were stratiﬁed for baseline mGFR levels into 6 classes (15–19, 20–29, 30–39, 40–49, 50–59, $60 ml/min per 1.73 m2).
M Metzger et al.: Low-Protein Diet and ESRD Risk CLINICAL RESEARCHassociated with a loss of kidney function that was faster
by 0.064  0.031 ml/min per year (P ¼ 0.039). Baseline
mGFR, proteinuria, diabetes, and mean blood pressure
were also signiﬁcantly associated with the rate of GFR
decline in this analysis.DISCUSSION
This study’s major new ﬁnding is that the increased
risk of progression to ESRD associated with higher DPI
is linear and has no threshold. This indicates that there
is no optimal level of protein intake in CKD with regardTable 4. Baseline dietary protein intake and other factors
associated with mGFR slope over time: linear mixed model
b ± SD P
Slope (ml/min per yr),a according
to baseline mGFR
$45 ml/min 1.899  0.182 <.0001
3044 ml/min 1.418  0.165 <.0001
<30 ml/min 1.160  0.158 <.0001
Other baseline factors associated
with mGFR slope over timeb
DPI-UE (per 0.1 g/kg per d) 0.064  0.031 0.03
Diabetes 0.486  0.213 0.02
Log protein-to-creatinine ratio 0.758  0.093 <0.0001
Mean blood pressure 0.017  0.009 0.05
mGFR, measured glomerular ﬁltration rate; DPI-UE, dietary protein intake estimated from
24-h urea excretion.
aCrude slope.
bAdjusted b for baseline mGFR (<30, 30–44, $45 ml/min), age, gender, origin (sub-
Saharan Africa, other), diabetes status, continuous mean blood pressure, urinary
protein-to-creatinine ratio (log-transformed), center, and number of mGFR
measurements.
Kidney International Reports (2018) 3, 105–114to mGFR decline, at least within the range observed in
this study (0.342.76 g/kg per day). This study also
showed that the risk of ESRD associated with higher
DPI did not signiﬁcantly differ by diabetes status, but
may be stronger at low GFR. The value of these ﬁnd-
ings is strengthened by the consistency of the risk
estimates provided by the 2 independent methods used
to assess DPI and the accurate measurement of GFR to
assess kidney function and its decline over time. In this
cohort of patients with optimal CKD management
including dietary counseling, we observed that only a
few (14%) met the recommended goal of DPI < 0.8 g/
kg per day, and a signiﬁcant number (20%) had DPI
exceeding the upper recommended limit of 1.3 g/kg per
day. Nonetheless, DPI was lower at lower mGFR values.
Low DPI levels were not associated with greater mor-
tality in this range, but very few patients (<2%) had a
DPI < 0.6 g/kg per day, the threshold below which
lowering DPI may become deleterious.
Our results conﬁrm and extend several previous
studies showing that lowering DPI beneﬁts CKD
patients.2,10,19–21 In a Cochrane Review of adults with
CKD and without diabetes from 10 RCTs, Fouque and
Laville reported a risk of kidney failure that was 32%
lower among patients with reduced, compared to
higher, protein intake.10 Among patients with type 1
diabetes, Hansen et al. showed that moderate dietary
protein restriction was associated with a risk of ESRD
or death 77% lower than with standard protein
intake.22 Another Cochrane Review concluded that111
CLINICAL RESEARCH M Metzger et al.: Low-Protein Diet and ESRD Riskreducing protein intake appeared to slightly slow
progression to renal failure in patients with type 1 and
type 2 diabetes, but not statistically signiﬁcantly so.23
In the meta-analysis by Pedrini et al., protein restric-
tion in CKD patients both with and without diabetes
was associated with slower progression of kidney dis-
ease.21 However, results from the original MDRD trial
were mixed.5,7–9 Among patients with moderate renal
disease (baseline GFR 2555 ml/min per 1.73 m2), GFR
declined more slowly and proteinuria was lower in
those assigned to a low-protein diet than in those with
a usual diet,5,6 but the groups did not differ signiﬁ-
cantly in terms of ESRD risk or all-cause mortality in
the long term.8 As Levey et al. explained in 1999,7
however, the initial GFR reduction observed in the
ﬁrst 4 months after patients with moderate renal dis-
ease start a low-protein diet is simply the (short-term
and) normal response of the kidney (whether healthy
or diseased) to a reduction in protein intake. The mean
GFR decline in the subsequent 32 months was signiﬁ-
cantly slower (P¼ 0.009) in these patients than in those
assigned to the usual protein diet. In contrast, among
patients with advanced renal disease (baseline GFR
1324 ml/min per 1.73 m2), GFR did not decline more
slowly for those on a very low-protein diet supple-
mented with keto acids compared with those on a low-
protein diet,5,6 and a long-term follow-up study even
observed an excess risk of death.9 Our study showed
no signiﬁcant excess mortality in patients achieving a
DPI < 0.8 g/kg per day but very few (< 2%) achieved
levels as low as 0.6 g/kg per day, as in the
MDRD study. Further studies have shown that a keto
acidsupplemented very-lowprotein diet has a
beneﬁcial effect on rate of progression among advanced
CKD patients,2 on dialysis initiation,2,24 and on long-
term outcome.2,19 Variable adherence to dietary pro-
tein restrictions may explain the differences between
studies. Indeed, intense nutrition education has been
shown to be more effective than standard dietary
counseling in reducing protein intake.25
Our ﬁndings are also in line with those from
observational studies in the general population. In the
Nurses’ Health Study, high protein intake was associ-
ated with a greater decline in kidney function among
women with mild CKD, compared to those with normal
renal function.20 Other data from this study showed
that a Western dietary pattern, deﬁned by high intake
of red and processed meats, saturated fats, and sweets,
was also associated with signiﬁcantly higher risks of
microalbuminuria and of rapid kidney function decline
than among women eating less of these foods.26 This
ﬁnding is consistent with that from the Framingham
Heart Study showing higher risk for developing
adverse kidney measures in participants with low112adherence to meat and legume consumption recom-
mendations.27 Likewise, in the population-based Gub-
bio study, which included men and women aged 45 to
64 years, high protein intake was associated with a
higher estimated GFR at baseline and greater GFR
decline over time.28 Moreover, higher protein intake
was recently associated with a higher risk of ESRD in
the Singapore Chinese Health Study, a population-
based cohort of Chinese adults followed up for 15
years.29 Interestingly, red meat intake showed a strong
dose-dependent relation with ESRD risk, whereas
intake of poultry, ﬁsh, eggs, and dairy products were
not associated with ESRD risk.
The mechanism underlying the deleterious effect of
high DPI on CKD progression is well understood.
Whereas carbohydrate and lipid metabolism produce
only CO2 and H2O, which are easily excreted by the
lungs and kidneys, protein metabolism leads to the
production of nitrogen end products (urea, ammonia,
uric acid, etc.) and strong acids that are excreted by
the kidney and concentrated in urine at much higher
levels than in plasma. A protein meal or an amino acid
infusion have been shown to induce a rapid and
reversible increase in GFR that is thought to depend on
inhibition of tubuloglomerular feedback, involving the
renin-angiotensin system and nitric oxide, and
possibly inﬂuenced by vasopressin and glucagon.30
Hyperﬁltration induces a vicious circle because of the
work overload imposed on the remaining nephrons in
terms of ﬁltration and reabsorption of the extra solutes
ﬁltered (including sodium and other electrolytes,
glucose, amino acids, and small proteins). This pro-
gressive insult leads to ESRD.31 Our ﬁnding that the
HR for ESRD associated with higher DPI was stronger
at lower GFR may reﬂect a potentially stronger impact
of this work overload when renal function is reduced.
In contrast, lowering protein intake during experi-
mental kidney disease is associated with a reverse
protective effect, for example, reduced hyperﬁltration
and less severe and less progressive renal insult, as
reported during the ﬁrst 4 months of the MDRD
study.7,8 It is important to emphasize that although the
present study is very useful in solidifying our
understanding about the deleterious renal impact of
high protein intake (i.e., protein intake that is higher
than what is physiologically necessary for most peo-
ple), it cannot inform about a lower safety threshold,
and the risks and beneﬁts of very-lowprotein diet,
because of the few number of patients with a
DPI < 0.6 g/kg per day in this study.
Major strengths of this study include its large
sample size, the extensive patient phenotyping
including a number of laboratory measurements per-
formed with reference methods, as well as theKidney International Reports (2018) 3, 105–114
M Metzger et al.: Low-Protein Diet and ESRD Risk CLINICAL RESEARCHavailability of 2 independent methods for assessing
DPI, namely, 24-hour urinary urea excretion and a 7-
day food record.12 A key advantage of this study is
that GFR was measured by a validated method and not
estimated from serum creatinine concentration, which
may be affected by protein intake.32 It should be noted
that our ﬁndings about the association of DPI with
CKD progression were consistent regardless of whether
we used ESRD incidence or mGFR decline as the
outcome. Several studies have raised questions about
the accuracy and validity of questionnaires assessing
dietary intake.33,34 Although 24-hour urine urea
excretion is a reliable biomarker, it is rarely used in
epidemiological studies to assess protein intake. In this
study, we found that both methods provided similar
mean DPI at the population level, despite their rela-
tively poor agreement at the individual level according
to BlandAltman plots. The consistent risk estimates
for ESRD and mortality yielded by these 2 methods
strengthen our ﬁndings.
This study also has limitations. First, it is an obser-
vational study and thus precludes any causal inter-
pretation. In particular, it is difﬁcult to disentangle
whether the association of lower DPI with lower GFR
observed at baseline resulted from successful dietary
advice or from spontaneous reduction of DPI with GFR
decline. Nevertheless, observational studies have some
advantages over clinical trials, notably the ability to
study a large range of DPI levels without predeﬁned
risk thresholds. They are therefore complementary to
and reinforce ﬁndings from clinical trials. Moreover,
several rodent studies have clearly established causal-
ity between the level of protein intake and CKD pro-
gression.35 Second, we cannot rule out the possibility
that low DPI may mask the symptoms of uremia and
thus delay the need to start dialysis, although without
slowing the rate of CKD progression. The association
between lower DPI at baseline and subsequent steeper
kidney function decline nonetheless suggests that DPI
affects CKD progression. Finally, total energy intake
was not available in all patients, but we were able to
show in a subgroup that adjusting for total energy
intake did not abolish the associations observed be-
tween DPI and the outcomes.
In conclusion, our study shows that usual dietary
protein intake, whether measured by urea excretion or
7-day food records in these patients under nephrology
care, is higher than expected at each stage of CKD; this
ﬁnding reﬂects poor adherence to the recommenda-
tions. The linear no-threshold relation shown in this
study between either method of DPI assessment and
both the onset of kidney failure and steeper mGFR
decline strengthens the evidence that a moderately low
DPI is beneﬁcial for reducing CKD progression. TheKidney International Reports (2018) 3, 105–114lack of impact on mortality reﬂects the safety of low
DPI, at least in the range observed in this study, for
example, in patients with DPI > 0.6 g/kg per day.
Overall, these ﬁndings underline the importance of
dietary counseling and reasonable protein intake
reduction to preserve kidney function in CKD patients.DISCLOSURE
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SUPPLEMENTARY MATERIAL
Supplementary Material. Figure S1 shows the distribution
of creatinine clearance ratio (24-hour Ccreat O 30-minute
Ccreat). Figure S2 shows the study of the agreement
between the 2 dietary protein intake estimates. Figure S3
shows the measured glomerular ﬁltration rate (mGFR)
subgroup analysis of end-stage renal disease (ESRD) risk
according to dietary protein intake estimated from 24-
hour urinary urea excretion or 7-day food records. Table
S1 shows the hazard ratios for ESRD in 1412 patients
with chronic kidney disease stages 1 to 4 at baseline.
Table S2 shows the hazard ratios for death before ESRD
in 1412 patients with chronic kidney disease stages 1 to 4
at baseline.
Supplementary material is linked to the online version of
the paper at www.kireports.org.
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